TW200720260A - Prokineticin 1 receptor antagonists - Google Patents
Prokineticin 1 receptor antagonistsInfo
- Publication number
- TW200720260A TW200720260A TW095109979A TW95109979A TW200720260A TW 200720260 A TW200720260 A TW 200720260A TW 095109979 A TW095109979 A TW 095109979A TW 95109979 A TW95109979 A TW 95109979A TW 200720260 A TW200720260 A TW 200720260A
- Authority
- TW
- Taiwan
- Prior art keywords
- prokineticin
- receptor antagonists
- compounds
- prokinetin
- intermediates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
- C07D251/20—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with no nitrogen atoms directly attached to a ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/30—Only oxygen atoms
- C07D251/34—Cyanuric or isocyanuric esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/38—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/42—One nitrogen atom
- C07D251/46—One nitrogen atom with oxygen or sulfur atoms attached to the two other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66500205P | 2005-03-24 | 2005-03-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200720260A true TW200720260A (en) | 2007-06-01 |
Family
ID=36609632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095109979A TW200720260A (en) | 2005-03-24 | 2006-03-23 | Prokineticin 1 receptor antagonists |
Country Status (13)
Country | Link |
---|---|
US (2) | US7968710B2 (zh) |
EP (1) | EP1866290B1 (zh) |
JP (1) | JP2008534500A (zh) |
KR (1) | KR20080006564A (zh) |
CN (2) | CN101326168A (zh) |
AR (1) | AR053451A1 (zh) |
AU (1) | AU2006229793A1 (zh) |
BR (1) | BRPI0609315A2 (zh) |
CA (1) | CA2602576A1 (zh) |
MX (1) | MX2007011848A (zh) |
MY (1) | MY153719A (zh) |
TW (1) | TW200720260A (zh) |
WO (1) | WO2006104715A1 (zh) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080006564A (ko) * | 2005-03-24 | 2008-01-16 | 얀센 파마슈티카 엔.브이. | 프로키네티신 1 수용체 길항제 |
JP2009518409A (ja) * | 2005-12-06 | 2009-05-07 | メルク エンド カムパニー インコーポレーテッド | モルホリンカルボキサミドプロキネチシン受容体アンタゴニスト |
AR058407A1 (es) * | 2005-12-29 | 2008-01-30 | Janssen Pharmaceutica Nv | Antagonistas del receptor de proquineticina 2 |
CA2635842C (en) * | 2005-12-29 | 2015-02-17 | Janssen Pharmaceutica N.V. | Prokineticin 1 receptor antagonists |
WO2009058653A1 (en) * | 2007-10-30 | 2009-05-07 | Janssen Pharmaceutica N.V. | Amino-heteroaryl-containing prokineticin 1 receptor antagonists |
WO2010077976A2 (en) * | 2008-12-17 | 2010-07-08 | The Regents Of The University Of California | Prokineticin receptor antagonists and uses thereof |
AU2010214356B2 (en) | 2009-02-13 | 2014-10-30 | Shionogi & Co. Ltd. | Novel triazine derivative and pharmaceutical composition containing same |
EP2585069A1 (en) * | 2010-06-28 | 2013-05-01 | Janssen Pharmaceutica, N.V. | Prokineticin 1 receptor antagonists for the treatment of pain |
EP2585068A1 (en) * | 2010-06-28 | 2013-05-01 | Janssen Pharmaceutica, N.V. | Prokineticin 1 receptor antagonists for the treatment of pain |
WO2012020742A1 (ja) | 2010-08-10 | 2012-02-16 | 塩野義製薬株式会社 | 新規複素環誘導体およびそれらを含有する医薬組成物 |
US9718790B2 (en) | 2010-08-10 | 2017-08-01 | Shionogi & Co., Ltd. | Triazine derivative and pharmaceutical composition having an analgesic activity comprising the same |
US9550763B2 (en) | 2012-02-09 | 2017-01-24 | Shionogi & Co., Ltd. | Heterocyclic ring and carbocyclic derivative |
MX353470B (es) * | 2012-03-30 | 2018-01-15 | Nissan Chemical Ind Ltd | Compuesto de triazinona e inhibidor de canal de calcio tipo t. |
KR20150084007A (ko) | 2012-11-13 | 2015-07-21 | 리제너론 파아마슈티컬스, 인크. | 항-프로키네티신 수용체 (prokr) 항체 및 이의 용도 |
TWI637949B (zh) | 2013-06-14 | 2018-10-11 | 塩野義製藥股份有限公司 | 胺基三衍生物及含有其等之醫藥組合物 |
JP6422164B2 (ja) | 2013-12-26 | 2018-11-14 | 塩野義製薬株式会社 | 含窒素6員環誘導体およびそれらを含有する医薬組成物 |
CN107709299B (zh) | 2015-04-24 | 2021-07-16 | 盐野义制药株式会社 | 6元杂环衍生物及含有其的药物组合物 |
AU2017345923B2 (en) | 2016-10-17 | 2021-11-11 | Shionogi & Co., Ltd. | Bicyclic nitrogenated heterocyclic derivative and pharmaceutical composition containing same |
CA3195272C (en) * | 2021-04-14 | 2024-02-13 | Shionogi & Co., Ltd. | Triazine derivative having virus propagation inhibitory effect, and pharmaceutical composition containing same |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1504304A (en) * | 1974-02-15 | 1978-03-15 | Ici Ltd | Process of combating fungal and bacterial infections of plants with triazine dione derivatives |
US6485938B1 (en) | 1999-11-16 | 2002-11-26 | Zymogenetics, Inc. | Nucleic acid molecules that encodes human Zven1 |
AU2002230778A1 (en) | 2000-11-03 | 2002-05-15 | The Regents Of The University Of California | Prokineticin polypeptides, related compositions and methods |
WO2003084936A2 (en) * | 2002-04-10 | 2003-10-16 | Orchid Chemicals & Pharmaceuticals Limited | Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
CA2500962A1 (en) * | 2002-10-07 | 2004-04-15 | Zymogenetics, Inc. | Uses of human zven proteins and polynucleotides |
WO2004087054A2 (en) | 2003-03-25 | 2004-10-14 | The Regents Of The University Of California | Methods for modulating gastric secretion using prokineticin receptor antagonists. |
US20050170455A1 (en) | 2003-06-20 | 2005-08-04 | Qun-Yong Zhou | Novel prokineticin receptor isoforms and methods of use |
BRPI0412327A (pt) | 2003-07-07 | 2006-09-05 | Neurocrine Biosciences Inc | derivados de pirimidina-2,4-diona como antagonistas de receptor de hormÈnio liberador de gonadotropina |
US20060019338A1 (en) | 2004-03-05 | 2006-01-26 | Qun-Yong Zhou | Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
KR20080006564A (ko) * | 2005-03-24 | 2008-01-16 | 얀센 파마슈티카 엔.브이. | 프로키네티신 1 수용체 길항제 |
JP2008537548A (ja) * | 2005-03-24 | 2008-09-18 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | プロキネチシン1受容体 |
US20080045535A1 (en) | 2005-03-24 | 2008-02-21 | Coats Steven J | Prokineticin 2 receptor antagonists |
CA2635842C (en) * | 2005-12-29 | 2015-02-17 | Janssen Pharmaceutica N.V. | Prokineticin 1 receptor antagonists |
-
2006
- 2006-03-14 KR KR1020077024515A patent/KR20080006564A/ko not_active Application Discontinuation
- 2006-03-14 EP EP06738649.0A patent/EP1866290B1/en active Active
- 2006-03-14 AU AU2006229793A patent/AU2006229793A1/en not_active Abandoned
- 2006-03-14 BR BRPI0609315-9A patent/BRPI0609315A2/pt not_active Application Discontinuation
- 2006-03-14 MX MX2007011848A patent/MX2007011848A/es unknown
- 2006-03-14 JP JP2008503045A patent/JP2008534500A/ja not_active Withdrawn
- 2006-03-14 US US11/375,407 patent/US7968710B2/en not_active Expired - Fee Related
- 2006-03-14 CA CA002602576A patent/CA2602576A1/en not_active Abandoned
- 2006-03-14 WO PCT/US2006/009613 patent/WO2006104715A1/en active Application Filing
- 2006-03-14 CN CNA2006800178008A patent/CN101326168A/zh active Pending
- 2006-03-15 CN CNA200680017645XA patent/CN101252934A/zh active Pending
- 2006-03-23 AR ARP060101155A patent/AR053451A1/es unknown
- 2006-03-23 MY MYPI20061293A patent/MY153719A/en unknown
- 2006-03-23 TW TW095109979A patent/TW200720260A/zh unknown
-
2011
- 2011-05-23 US US13/113,751 patent/US8362247B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AR053451A1 (es) | 2007-05-09 |
AU2006229793A1 (en) | 2006-10-05 |
CN101326168A (zh) | 2008-12-17 |
MY153719A (en) | 2015-03-13 |
US7968710B2 (en) | 2011-06-28 |
JP2008534500A (ja) | 2008-08-28 |
BRPI0609315A2 (pt) | 2010-03-09 |
US8362247B2 (en) | 2013-01-29 |
US20120129862A1 (en) | 2012-05-24 |
EP1866290A1 (en) | 2007-12-19 |
CN101252934A (zh) | 2008-08-27 |
CA2602576A1 (en) | 2006-10-05 |
US20060235018A1 (en) | 2006-10-19 |
KR20080006564A (ko) | 2008-01-16 |
WO2006104715A1 (en) | 2006-10-05 |
EP1866290B1 (en) | 2013-05-01 |
MX2007011848A (es) | 2008-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200720260A (en) | Prokineticin 1 receptor antagonists | |
TW200716566A (en) | Prokineticin 2 receptor antagonists | |
WO2007079163A3 (en) | Prokineticin 1 receptor antagonists | |
WO2007079214A3 (en) | Prokineticin 2 receptor antagonists | |
WO2003028641A3 (en) | Mch receptor antagonists | |
SE0303180D0 (sv) | Novel compounds | |
UA99620C2 (en) | Pyridyl piperidine orexin receptor antagonists | |
SE0302232D0 (sv) | Novel Compounds | |
TW200612892A (en) | Novel compounds | |
MXPA05012680A (es) | Indoles novedosos de 3-azufre sustituidos. | |
MX2007002393A (es) | Compuestos indolicos sustituidos y su uso como moduladores del receptor de 5-hidroxitriptamina 6 (5-ht6). | |
WO2007041077A3 (en) | Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes | |
TW200407305A (en) | Novel compounds | |
TW200630336A (en) | Novel compounds | |
HK1098460A1 (en) | Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders | |
TW200621690A (en) | Novel compounds | |
TW200745003A (en) | Novel compounds | |
TW200732296A (en) | Novel compounds | |
MX2008002805A (es) | Derivados de carboxamida como antagonistas del receptor muscarinico. | |
WO2007041076A3 (en) | 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes | |
IS8377A (is) | Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns | |
MY147677A (en) | Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases | |
MX2009003981A (es) | Agentes moduladores del receptor de calcio. | |
GB0524814D0 (en) | Compounds | |
JO2747B1 (en) | Vehicles |